Relapsed or refractory Hodgkin lymphoma - pembrolizumab initial PBS authority application form (PB232)

Use this form to apply for initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with pembrolizumab for relapsed or refractory Hodgkin lymphoma.